Cancer vs Digitalocean
Kustiq lines up Cancer and Digitaloceanon tech stack, hiring posture, funding, and customer signals in 60 seconds, stamped with each profile's last-verified date, free to compare and from $0.20 to profile your own.
Cancer and Digitalocean at a glance
Cancer
Since its establishment in 1937, the National Cancer Institute has supported and advanced cancer research in many ways.
Digitalocean
DigitalOcean is a publicly traded (NYSE: DOCN) cloud IaaS provider offering virtual machines (Droplets), Kubernetes, managed databases, serverless functions, and GPU/AI infrastructure (Gradient AI) primarily to developers, startups, and SMBs worldwide. With $692.9M in 2023 revenue and brands including Cloudways and Paperspace, they differentiate from AWS and GCP through simpler pricing and developer-friendly tooling.
Cancer vs Digitalocean: TL;DR
- Cancer focuses on research since 1937; DigitalOcean trades publicly on NYSE: DOCN.
- DigitalOcean generated $692.9M revenue in 2023 offering Droplets and Kubernetes; Cancer operates as research institute.
- DigitalOcean serves developers, startups, SMBs globally; Cancer advances cancer research through National Institute.
| Dimension | Cancer | Digitalocean |
|---|---|---|
| Vertical | Healthcare | SaaS |
| Segment | Provider/Health System | Infrastructure/DevTools |
| Founded | 2019 | |
| Employees | 1001-5000 | 1001-5000 |
| Location | ||
| Funding | Growth ($2.37M) | |
| G2 rating | ||
| Pricing page |
Known competitors
Cancer
Digitalocean
Compare another pair
Cancer is already loaded. Swap one side or both.
Cancer vs Digitalocean: side-by-side facts
- Employees
- 1001-5000
- Founded
- 2019
- Vertical
- Healthcare
- Employees
- 1001-5000
- Funding
- $2.37M
- Vertical
- SaaS
Take any comparison deeper
Full profiles add buying signals, pain signals, account scoring, and recommended contacts. 1 free profile / week, no signup · 3 / week with a free account.